Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: Ann Surg Oncol. 2020 Nov 23;28(7):3685–3694. doi: 10.1245/s10434-020-09369-7

Table 2:

Multivariate Analysis of Predictors of recurrence-free survival (n = 480)

Variable Hazard Ratio 95% Hazard Ratio CI P-value

HAI therapy 0.68 0.53 – 0.87 < 0.01
Age 0.10 0.99 – 1.01 0.89
Number of lesions 1.13 1.07 –1.20 < 0.01
Size of largest lesion 1.08 1.04 – 1.13 < 0.01
Laterality (left) 1.13 0.89 – 1.44 0.32
Lesions ablated 1.36 1.03 – 1.79 0.03
Sex (male) 1.12 0.89 – 1.40 0.35
RAS (mutant) 1.49 1.17 – 1.88 < 0.01
Extra-hepatic disease 2.01 1.33 – 3.03 < 0.01
2-stage hepatectomy 1.39 0.93 – 2.08 0.11
DFI < 12 months 1.74 1.26 – 2.42 < 0.01
Node positive tumor 1.58 1.23 – 2.03 < 0.01
Positive margins 1.79 1.23 – 2.60 < 0.01

Abbreviations: HAI = hepatic artery infusion; DFI = disease-free interval